A randomised study of two cotrimoxazole doses in primary prophylaxis against PCP and cerebral toxoplasmosis

Marie‐Christine Payen(Université Libre de Bruxelles), Nathan Clumeck(Centre Hospitalier Universitaire de Saint-Pierre), N. Van Cutsem, Stéphane De Wit, J Demonty, Jean‐Paul Van Vooren(Université Libre de Bruxelles), Jean Legrand, Marianne Farber, Bernadette Sommereijns

Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)

January 1, 1996

Cited by 0

Related Papers

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

|Hepatology|2006|4.8k

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

|Nature Medicine|1996|632

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

|The Lancet Infectious Diseases|2011|172

The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003

|Cancer|2004|143

Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies

|Cancer|2010|141